The legal action, spearheaded by New York-based Pomerantz LLP, centers on allegations of securities fraud and unlawful business practices by the company’s leadership. Scrutiny intensified on June 1, 2026, when Reuters reported that the Brussels Public Prosecutor’s Office was examining over $582.5 million in suspicious transactions linked to Wise’s European division. Prosecutors have investigated potential ties to money laundering, corruption, and drug trafficking, leading to a sharp two-day decline in the company's stock price, which dropped nearly 10%.

Pressure mounted further on July 24, 2026, after The Wall Street Journal revealed that U.S. regulators had rejected Wise’s application for a national trust bank license. Officials cited critical deficiencies in the firm’s anti-money laundering and counter-terrorism financing protocols. That disclosure triggered an additional 6.2% slide in share value, closing at $11.33. Investors seeking to participate in the class action may contact Danielle Peyton at Pomerantz LLP to review their standing and obtain documentation related to the complaint.